<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00879346</url>
  </required_header>
  <id_info>
    <org_study_id>D0102C00011</org_study_id>
    <nct_id>NCT00879346</nct_id>
  </id_info>
  <brief_title>A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets</brief_title>
  <official_title>A Randomised, Open-label, Phase I Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phase I, randomised, open label, 3-period crossover study in healthy male subjects to
      investigate the effect of food on the pharmacokinetics of AZD8931 and to investigate the
      safety and tolerability of AZD8931.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To investigate the effect of food on the pharmacokinetics of AZD8931 160mg oral dose</measure>
    <time_frame>Multiple blood PK samples taken between predose to up to 5 days post last dose</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the safety profile by assessment of adverse events, physical examination, pulse, blood pressure, clinical chemistry, haematology, urinalysis &amp; ECG</measure>
    <time_frame>Maximus of 7 weeks (From time of consent to last visit including any follow-up)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>160mg oral dose of AZD8931</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AZD8931</intervention_name>
    <description>160mg oral single dose (4 x 40mg tablets)</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provision of written informed consent

          -  Body mass index (BMI) between 19 and 30 kg/m2

        Exclusion Criteria:

          -  Use of any prescribed or non-prescribed medication (including analgesics, herbal
             remedies, vitamins and minerals) during the two weeks prior to the first
             administration of investigational product

          -  Administration of another investigational medicinal product in the 3 months before the
             start of dosing in this study

          -  Definite or suspected clinically relevant personal history of adverse drug reactions,
             or drug hypersensitivity
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emeline Ramos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AstraZeneca, Clinical Pharamcology Unit, Alderley Park</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mary Stuart, MD</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Alderley Park</city>
        <state>Cheshire</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2009</study_first_submitted>
  <study_first_submitted_qc>April 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2009</study_first_posted>
  <last_update_submitted>October 22, 2009</last_update_submitted>
  <last_update_submitted_qc>October 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Mary Staurt, Medical Science Director</name_title>
    <organization>AstraZeneca Pharmaceuticals</organization>
  </responsible_party>
  <keyword>Healthy Volunteers</keyword>
  <keyword>ADME</keyword>
  <keyword>Healthy male volunteers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

